{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:19:45Z","timestamp":1790295585609,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012459","name":"Chongqing Graduate Student Research Innovation Project","doi-asserted-by":"publisher","award":["CYB22207"],"award-info":[{"award-number":["CYB22207"]}],"id":[{"id":"10.13039\/501100012459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115051","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T05:01:49Z","timestamp":1687928509000},"page":"115051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The anti-fibrotic efficacy of adelmidrol depends on hepatic PPAR\u03b3 levels"],"prefix":"10.1016","volume":"165","author":[{"given":"Huanyu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2021.10.002","article-title":"Mechanical communication in fibrosis progression","volume":"32","author":"Long","year":"2022","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"42","key":"10.1016\/j.biopha.2023.115051_bib4","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.3748\/wjg.v24.i42.4728","article-title":"Liver as a target of human immunodeficiency virus infection","volume":"24","author":"Ganesan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.115051_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/112_2018_10","article-title":"Targeting Oxidative Stress for the Treatment of Liver Fibrosis","volume":"175","author":"Luangmonkong","year":"2018","journal-title":"Rev. Physiol. Biochem Pharm."},{"issue":"33","key":"10.1016\/j.biopha.2023.115051_bib6","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.3748\/wjg.v25.i33.4835","article-title":"Crosstalk network among multiple inflammatory mediators in liver fibrosis","volume":"25","author":"Zhangdi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.115051_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107791","article-title":"Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis","volume":"222","author":"Han","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.115051_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114433","article-title":"Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-\u0263 and NF-kB mechanism","volume":"280","author":"de Souza Basso","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115051_bib9","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/jcmm.15028","article-title":"Therapeutic potential of PPAR\u03b3 natural agonists in liver diseases","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"8","key":"10.1016\/j.biopha.2023.115051_bib10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.pain.2013.04.039","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages","volume":"154","author":"Hasegawa-Moriyama","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2012.08.039","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization","volume":"426","author":"Hasegawa-Moriyama","year":"2012","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.biopha.2023.115051_bib12","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s10620-019-5462-8","article-title":"Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis","volume":"64","author":"Zhi","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.115051_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1746-6148-8-230","article-title":"Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis","volume":"8","author":"Cerrato","year":"2012","journal-title":"BMC Vet. Res"},{"issue":"6","key":"10.1016\/j.biopha.2023.115051_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.0959-4493.2001.00272.x","article-title":"The mast cell in wound healing","volume":"12","author":"Noli","year":"2001","journal-title":"Vet. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13075-016-1189-5","article-title":"Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats","volume":"18","author":"Di Paola","year":"2016","journal-title":"Arthritis Res Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115051_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.116.105668","article-title":"Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease","volume":"90","author":"Cordaro","year":"2016","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2023.115051_bib17","first-page":"9","article-title":"Adelmidrol: a new promising antioxidant and anti-inflammatory therapeutic tool in pulmonary fibrosis","author":"Fusco","year":"2020","journal-title":"Antioxid. (Basel)"},{"issue":"6","key":"10.1016\/j.biopha.2023.115051_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115051_bib19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biopha.2023.115051_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.biopha.2023.115051_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.biopha.2023.115051_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115051_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.biopha.2023.115051_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"G\u00f3mez-Lech\u00f3n","year":"2007","journal-title":"Chem. Biol. Inter."},{"issue":"8","key":"10.1016\/j.biopha.2023.115051_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41575-020-0304-x","article-title":"Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis","volume":"17","author":"Ramachandran","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7783","key":"10.1016\/j.biopha.2023.115051_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.biopha.2023.115051_bib28","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPAR\u03b3-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Wolf Greenstein","year":"2017","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115051_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2005.079194","article-title":"Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats","volume":"55","author":"Leclercq","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115051_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lfs.2014.10.014","article-title":"Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor \u03b3 activation","volume":"120","author":"Chang","year":"2015","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115051_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13105-020-00777-7","article-title":"Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-\u03b21\/Smad signaling pathway","volume":"77","author":"Ni","year":"2021","journal-title":"J. Physiol. Biochem"},{"issue":"7","key":"10.1016\/j.biopha.2023.115051_bib34","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115051_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41598-021-04036-7","article-title":"Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver","volume":"12","author":"Ebihara","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115051_bib36","doi-asserted-by":"crossref","first-page":"9735083","DOI":"10.1155\/2020\/9735083","article-title":"Loss of Hepatocyte-Specific PPAR\u03b3 Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet","volume":"2020","author":"Cordoba-Chacon","year":"2020","journal-title":"PPAR Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115051_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:30:19Z","timestamp":1777879819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":37,"alternative-id":["S0753332223008417"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115051","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-fibrotic efficacy of adelmidrol depends on hepatic PPAR\u03b3 levels","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115051"}}